ARMS2 and age-related macular degeneration: ARMS2 protein was reported to initiates complement activation by binding to human apoptotic and necrotic cells membrane, as consequence, variants affecting this protein may have an impact on dysregulation of the complement system which is a significant driver of AMD pathogenesis [13].